Glabridin also exhibited an anti-inflammatory effect against diabetes-related vascular dysfunction by downregulating LPS-induced NO production, as well as the expression of inducible nitric oxide synthase (iNOS) gene under high-glucose conditions [34]. The gene discussed is NOS2; the disease is diabetes mellitus.